期刊文献+

相变高分子微球增效高强度聚焦超声消融裸鼠骨肉瘤

Application of phase-change type micropheres enhancing the efficacy of high intensity focused ultrasound ablating osteosarcoma in nude mice
下载PDF
导出
摘要 目的制备相变高分子微球,观察其增效高强度聚焦超声(HIFU)消融裸鼠骨肉瘤模型的效果。方法制备包裹液态氟碳的高分子微球,检测其形态、结构、粒径电位及相变条件;建立裸鼠骨肉瘤模型,随机分为空白组(不予处理)、对照组(注射生理盐水)和实验组1、2、3(注射稀释倍数分别为5、10、20倍的Pct-MP溶液),处理后立即用海级星对肿瘤进行辐照。于辐照后即刻和72h提取标本并观察坏死面积、行HE染色,并对72h提取的标本的坏死周边组织进行细胞增殖和凋亡测定。结果成功制备相变高分子微球;HIFU辐照后即刻提取的标本,实验组1、2的坏死面积与对照组差异均有统计学意义(P均<0.05),但与实验组3的差异无统计学意义(P>0.05);72h后提取的标本,实验组1、2的坏死面积进一步扩大、与辐照后即刻提取的标本的差异有统计学意义(P均<0.05)。HIFU辐照72h后,实验组1、2、3与对照组间坏死周边组织的凋亡和增殖指数差异均有统计学意义(P均<0.05)。结论在骨肉瘤裸鼠模型中,自制相变高分子微球能够增强HIFU对于骨肉瘤的消融效果,增强作用与微球浓度有关。 Objective To prepare the phase-change type microspheres (Pct-MP) and observe the effect of high intensity focused ultrasound (HIFU) ablating xenograft tumor model of human osteosarcoma in nude mice. Methods Pct-MP was prepared and its form, particle size, surface potential and the condition of phase-change were detected. Xenograft tumor model of human osteosarcoma were established and randomly divided into blank group (without any intervention), control group (treated with physiological saline) and experimental group 1, 2, 3 (treated with the Pct-MP emulsion diluted 5, 10 and 20 times respectively), then each group was subjected to the HIFU ablation immediately. Specimens were taken to HE staining, necrosis area of osteosarcoma were calculated and compared immediately and 72 h after HIFU ablation. Prolifera- tion and apoptosis changes of the targeted region were analyzed 72 h after HIFU ablation. Results Pct-MP was prepared successfully. There were significant differences in the area of necrosis of osteosarcoma after the HIFU ablation between the control group and experimental group 1, 2 (both P^0.05), but not with experimental group 3 (P〈0.05). Experimental group 1 and experimental group 2 had a lager area of necrosis 72 h after HIFU ablation, compared to that after the HIFU ablation immediately (both P〈0.05). There were significant differences in proliferation and apoptotic index of the target regions between the control group and all the experimental groups (all P〈0.05). Conclusion In the xenograft osteosarco- ma model of nude mice, the Pct-MP can enhance the efficacy of HIFU ablating osteosarcoma, and the effects rely on the concentration of Pct-MP.
出处 《中国介入影像与治疗学》 CSCD 北大核心 2015年第9期563-568,共6页 Chinese Journal of Interventional Imaging and Therapy
基金 国家自然科学基金(81272005)
关键词 高强度聚焦超声消融 骨肉瘤 相变微球 High intensity focused ultrasound ablation Osteosarcoma Phase-change type microspheres
  • 相关文献

参考文献21

  • 1Luetke A, Meyers PA, Lewis I, et al. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev, 2014,40(4):523-532.
  • 2Tan PX, Yong BC, Wang J, et al. Analysis of the efficacy and prognosis of limb-salvage surgery for osteosarcoma around the knee. Eur J Surg Oncol, 2012,38(12):1171-1177.
  • 3Pan KL, Chan WH, Ong GB, et al. Limb salvage in osteosarcoma using autoclaved tumor-bearing bone. World J Surg Oncol, 2012,10:105-110.
  • 4Xu S, Yu X, Xu M, et al. Limb function and quality of life after various Reconstruction methods according to tumor location following resection of osteosarcoma in distal femur. BMC Musculoskelet Disord, 2014,15(1):453-462.
  • 5Liu T, Zhang Q, Guo X, et al. Treatment and outcome of malignant bone tumors of the proximal humerus: Biological versus endoprosthetic reconstruction. BMC Musculoskelet Disord, 2014,15:69-78.
  • 6Mei J, Zhu XZ, Wang ZY, et al. Functional outcomes and quality of Life in patients with osteosarcoma treated with amputation versus limb-salvage surgery: A systematic review and meta-analysis. Arch Orthop Trauma Surg, 2014,134(11):1507-1516.
  • 7Mankin HJ, Gebhardt MC, Jennings LC, et al. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res, 1996(324):86-97.
  • 8Yu W, Tang L, Lin F, et al. High-intensity focused ultrasound: Noninvasive treatment for local unresectable recurrence of osteosarcoma. Surg Oncol, 2015,24(1):9-15.
  • 9Li C, Wu P, Zhang L, et al. Osteosarcoma: Limb salvaging treatment by ultrasonographically guided high-intensity focused ultrasound. Cancer Biol Ther, 2009,8(12):1102-1108.
  • 10Kopechek JA, Park E, Mei CS, et al. Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo. J Healthc Eng, 2013,4(1):109-126.

二级参考文献12

  • 1冉海涛,任红,王志刚,郑元义,张群霞,许川山.自制高分子聚合材料超声造影剂显影效果动物实验研究[J].中华超声影像学杂志,2006,15(5):378-380. 被引量:11
  • 2Gross U,Rudiger S,Reichelt H. Perfluorocarbons:Chemically inert but biologically active[J].Journal of Fluorine Chemistry,1991,(02):155-161.
  • 3Wickline SA,Hughes M,Ngo FC. Blood contrast enhance ment with a novel,non-gaseous nanoparticle contrast agent[J].Academic Radiology,2002,(Suppl 2):S290-S293.
  • 4Beekman F,Mutton BF. Multi-modality imaging on track[J].European Journal of Nuclear Medicine and Molecular Imaging,2007,(09):1410-1414.
  • 5Beyer T,Pietrzyk U,Knoess C. Multi-modality imaging of uveal melanomas using combined PET/CT,high-resolution PET and MR imaging[J].Nuklearmedizin,2008,(02):73-79.
  • 6Rouse HC,Godoy MC,Lee WK. Imaging findings of unusual anorectal and perirectal pathology:A multi-modality approach[J].Clinical Radiology,2008,(12):1350-1360.doi:10.1016/j.crad.2008.06.008.
  • 7Mattrey RF,Long DM,Multer F. Perfluoroctylbromide:A reticuloendothclial-specific and tumor-imaging agent for compu ted tomography[J].Radiology,1982,(03):755-758.
  • 8Young SW,Enzmann DR,Long DM. Perfluoroctylbromide contast enhancement of malignant neoplasms:Preliminary obser vations[J].American Journal of Roentgenology,1981,(01):141-146.
  • 9Liuand MS,Long DM. Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography[J].Radiology,1977,(01):71-76.
  • 10Diaz-Lopez R,Tsapis N,Fattal E. Liquid perfluorocarbons as contrast agents for ultrasonography and 19F-MRI[J].Pharmaceutical Research,2010,(01):11-16.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部